Skip to main content

APPLIED DNA SCIENCES INC

For the period ended Sep 30, 2024. Filed Dec 17, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Dec 17, 2024

BNBX$0.16-56.8%Stored close · as of Jul 13, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
PART I​​
​​​
ITEM 1.BUSINESS5
ITEM 1A.RISK FACTORS17
ITEM 1B.UNRESOLVED STAFF COMMENTS35
ITEM 1CCYBERSECURITY35
ITEM 2.PROPERTIES36
ITEM 3.LEGAL PROCEEDINGS36
ITEM 4.MINE SAFETY DISCLOSURES36
​​​
PART II​
​​​
ITEM 5.MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES36
ITEM 6.RESERVED37
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS37
ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK51
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA51
ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE51
ITEM 9A.CONTROLS AND PROCEDURES51
ITEM 9B.OTHER INFORMATION52
ITEM 9CDISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS52
​​​
PART III​
​​​
ITEM 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE53
ITEM 11.EXECUTIVE COMPENSATION57
ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS63
ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE66
ITEM 14.PRINCIPAL ACCOUNTING FEES AND SERVICES67
​​​
PART IV
​​​
ITEM 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES68
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.